文献速递中医内科中药与中成药合理使用中医康复

整合医学辅助治疗慢性心力衰竭的有效性与安全性:伞形综述

The effectiveness and safety of integrative medicine for chronic heart failure: An umbrella review.
PubMed 文献 · Complement Ther Med · 2025-04-24

该伞形综述汇总了截至2024年4月的系统综述与Meta分析,评估整合医学辅助治疗心力衰竭的安全性与有效性。

要点

  • 辅酶Q10或太极可能降低心衰患者死亡率和住院率,证据确定性中等。
  • 针灸或静脉中药可能改善BNP,但证据确定性低至极低。
  • 维生素E可能增加住院率,应避免用于心衰患者。

核心结论

  • 多数整合医学 modality 辅助治疗心衰的证据仍有限,需要设计严谨、长期随访并评估临床有意义结局的随机对照试验。

研究设计与样本

  • 采用分层证据合成方法,纳入最新、高排名且全面的综述,并用AMSTAR评估综述质量,用GRADE评估主要结局证据确定性。

主要发现

  • 辅酶Q10或太极可能降低死亡率和住院率(中等确定性证据)。
  • 针灸或静脉中药可能改善BNP(低至极低确定性证据)。
  • 瑜伽和其他营养补充剂(包括左旋肉碱)的获益尚不明确。
  • 维生素E可能增加住院率,应避免使用。

关键数值与推荐

  • 主要结局包括死亡率、住院率以及严重程度或预后指标(如BNP和运动能力)。

临床怎么用

  • 可考虑将辅酶Q10或太极作为心衰的辅助治疗,但需结合中等确定性证据与患者具体情况。
  • 针灸或静脉中药改善BNP的证据确定性低,临床决策应谨慎。
  • 应避免使用维生素E,因其可能增加住院率。

局限性

  • 多数整合医学 modality 的证据有限,整体证据确定性不高。
  • 需要设计严谨、长期随访并评估临床有意义结局的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Heart failure (HF) is associated with multi-organ dysfunction and significant morbidity and mortality. Despite advances in treatment, prognosis remains poor, highlighting the need to explore adjunctive therapies such as integrative medicine. This umbrella review synthesises top-tier evidence from systematic reviews and meta-analyses of randomised controlled trials (RCTs) assessing the safety and effectiveness of integrative medicine in patients with HF, in order to inform clinical decision-making. METHODS: We searched MEDLINE, Cochrane, PsycINFO and EMBASE until April 2024. Primary outcomes included mortality, hospitalisation rates, and severity or prognostic indicators, including brain natriuretic peptide (BNP) and exercise capacity. A hierarchical evidence synthesis method was used whereby we included the most recent, highly ranked and comprehensive reviews for our research question. We assessed review quality using 'A MeaSurement Tool to Assess systematic Reviews' and, where possible, evidence certainty for our primary outcomes using the Grading of Recommendations Assessment, Development and Evaluation approach. RESULTS: Twenty-two reviews were included. Co-enzyme Q10 or Tai Chi may reduce mortality and hospitalisation rates (moderate certainty evidence), and acupuncture or intravenous Chinese herbal medicines may improve BNP (low to very low certainty evidence). The benefits of yoga and other nutrient supplements including L-carnitine remain unclear. Vitamin E may increase hospitalisation rates and should be avoided. CONCLUSION: The evidence for most integrative medicine modalities for adjunctive management of HF remains limited. Well-designed and rigorous RCTs are needed, particularly with long-term follow up and evaluation of clinically meaningful outcomes.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Chua WJ, Liu J, Lam K, et al. The effectiveness and safety of integrative medicine for chronic heart failure: An umbrella review. Complement Ther Med. 2025. PMID: 40287103. doi:10.1016/j.ctim.2025.103182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。